Skip to main content
letter
. 2017 Apr 18;56(6):1041–1043. doi: 10.1093/rheumatology/kex044

Fig. 1.

Fig. 1

BILAG-2004 organ systems with active disease in SLE patients eligible for belimumab

Number of individual patients scoring either an A or B on BILAG-2004 scoring system across the systems assessed.